Because Rymedi was Founded to Fight Global Epidemics Before COVID-19, We Take Great Pride in Creating the Workflow Solutions that Enable Businesses, Colleges, and Communities to Reopen
Rising To Meet Today's Health Challenges
Our co-founders came together in 2018 with the Onom Foundation, the government of Mongolia, the WHO, and diagnostic and pharmaceutical companies to tackle the Hepatitis C epidemic in Mongolia. By using the Rymedi platform, we were able to test, treat and validate the protocol that laid the foundation for Hepatitis C eradication in Mongolia. With the emergence of the COVID-19 pandemic, we shifted our proven protocol to focus on COVID testing, working with universities, diagnostic manufacturers, CLIA labs, and testing service providers to curb the spread of the pandemic. Leveraging our experience and proven technology, we developed three key solutions running on our Connected Health Platform to tackle numerous diseases and challenges facing healthcare worldwide.
Our Global Vision is to Expand Access to High Quality Healthcare. We Believe Digital Workflow Disease Treatment will Transform the Diagnosis of Life-threatening Diseases and Management of Chronic Medical Conditions Enabling them to Become more Efficient, Effective, and Available to All.
David Stefanich, MBA, MSc, MCA
David Stefanich is co-founder and CEO of Rymedi, a cloud-based disease testing and vaccine administration workflow management solution. A former CIO and CTO for global Fortune 500 companies, he specializes in technology architectures and software applications for highly-regulated industries. He has employed data-driven methodologies to improve compliance and operations in pharmaceutical manufacturing and supply chain management. An inorganic chemist by training, he combines his Masters’ degrees in Chemistry, Computer Science, and Global Finance to improve healthcare technology workflows. He is a founding member of the Blockchain in Healthcare Global IEEE ISTO.
Jason Cross, PhD, JD
Dr. Jason Cross (PhD, JD) is co-founder and Chief Strategy Officer for Rymedi. Jason’s area of expertise is business model innovation focused on expanding access to high quality healthcare. Cross was a professor at Duke University and Founding Director of the Innovation & Technology Policy Lab where he spearheaded value-based contracting between countries and pharmaceutical and medical device companies. He is also Chair of the Intellectual Property Subgroup of the IEEE Blockchain in Healthcare and Life Sciences Working Group.
What's New at Rymedi
A small medical tech company on the second floor of a historic brick building in downtown Greenville masterminded the software that kept Clemson University open during the coronavirus pandemic.
During The Drug Supply Chain Security Act Pilot Project Program and Enhanced Drug Distribution Security Public Meeting, Jason Cross spoke about DSCSA Implementation in Intra and Inter Healthcare System Medicine Transfers.
Rymedi Joins Carbon and Med Aditus CEOs Presenting on Data Management Innovation Enabling Distributed Manufacture of Quality Devices, Medicines and Vaccines
The 2020 Triangle Global Health Annual Conference will explore global health in the COVID-19 era. Global health organizations in North Carolina and around the world are leaders in our collective responses to the COVID-19 pandemic.
Why You'll Love Working at Rymedi
We’re a fast-growing company, and we’re always looking for talented individuals to join our team. Not only do we have a passion for making health smarter and more connected, we also have a passion for challenging and equipping people to grow their skills. Whether you work in sales or software, marketing or customer success, you might be a perfect fit for our team. When you work with us, you can expect:
- Competitive salaries
- Paid health, dental, and vision coverage
- 401K plan
- Health and wellness programs
- Other benefits
If you’d like to learn more about current opportunities, reach out to us by completing the form and tell us more about yourself.